The store will not work correctly when cookies are disabled.
(5-(1H-indol-3-yl)-1,3,4-oxadiazol-2-yl)(phenyl)methanone
ID: ALA4742365
PubChem CID: 162646825
Max Phase: Preclinical
Molecular Formula: C17H11N3O2
Molecular Weight: 289.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1ccccc1)c1nnc(-c2c[nH]c3ccccc23)o1
Standard InChI: InChI=1S/C17H11N3O2/c21-15(11-6-2-1-3-7-11)17-20-19-16(22-17)13-10-18-14-9-5-4-8-12(13)14/h1-10,18H
Standard InChI Key: CLDVKLRCUXLZTO-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
2.9124 -4.9526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9113 -5.7722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6193 -6.1811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6175 -4.5438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3261 -4.9490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3264 -5.7677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1051 -6.0204 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5861 -5.3579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1046 -4.6959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3536 -3.9223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1307 -3.6695 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1304 -2.8523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3531 -2.6000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8731 -3.2614 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7914 -2.3718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5380 -2.7039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7057 -1.5591 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6193 -3.5175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3652 -3.8497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0271 -3.3690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9383 -2.5524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1923 -2.2240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 2 0
9 10 1 0
12 15 1 0
15 16 1 0
15 17 2 0
16 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 289.29 | Molecular Weight (Monoisotopic): 289.0851 | AlogP: 3.45 | #Rotatable Bonds: 3 |
Polar Surface Area: 71.78 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.54 | CX Basic pKa: ┄ | CX LogP: 2.92 | CX LogD: 2.92 |
Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.59 | Np Likeness Score: -0.75 |
References
1. Tantak MP,Malik M,Klingler L,Olson Z,Kumar A,Sadana R,Kumar D. (2021) Indolyl-α-keto-1,3,4-oxadiazoles: Synthesis, anti-cell proliferation activity, and inhibition of tubulin polymerization., 37 [PMID:33556575] [10.1016/j.bmcl.2021.127842] |